Correlation Between Regeneron Pharmaceuticals and N2OFF
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and N2OFF at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and N2OFF into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and N2OFF Inc, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and N2OFF and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of N2OFF. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and N2OFF.
Diversification Opportunities for Regeneron Pharmaceuticals and N2OFF
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Regeneron and N2OFF is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and N2OFF Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on N2OFF Inc and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with N2OFF. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of N2OFF Inc has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and N2OFF go up and down completely randomly.
Pair Corralation between Regeneron Pharmaceuticals and N2OFF
Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the N2OFF. But the stock apears to be less risky and, when comparing its historical volatility, Regeneron Pharmaceuticals is 50.02 times less risky than N2OFF. The stock trades about -0.21 of its potential returns per unit of risk. The N2OFF Inc is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest 22.00 in N2OFF Inc on October 10, 2024 and sell it today you would earn a total of 162.00 from holding N2OFF Inc or generate 736.36% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Regeneron Pharmaceuticals vs. N2OFF Inc
Performance |
Timeline |
Regeneron Pharmaceuticals |
N2OFF Inc |
Regeneron Pharmaceuticals and N2OFF Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Regeneron Pharmaceuticals and N2OFF
The main advantage of trading using opposite Regeneron Pharmaceuticals and N2OFF positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, N2OFF can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in N2OFF will offset losses from the drop in N2OFF's long position.Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |